SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Merck trades in green on tying up with Greenpharma SAS

05 Jul 2013 Evaluate

Merck is currently trading at Rs. 642.00, up by 9.40 points or 1.49% from its previous closing of Rs. 632.60 on the BSE.

The scrip opened at Rs. 639.00 and has touched a high and low of Rs. 642.00 and Rs. 631.00 respectively. So far 831 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 699.00 on 10-Sep-2012 and a 52 week low of Rs. 530.00 on 09-Apr-2013.

Last one week high and low of the scrip stood at Rs. 660.00 and Rs. 628.60 respectively. The current market cap of the company is Rs. 1050.74 crore.

The promoters holding in the company stood at 51.80% while Institutions and Non-Institutions held 22.13% and 26.06% respectively.

Merck, a manufacturer of ingredients for cosmetics industry has entered into partnership pact with French firm Greenpharma SAS to market latter’s cosmetic ingredient ‘poppy seed extract’. As per the agreement, Merck will market the active ingredient globally under its umbrella brand RonaCare, as of September 2013.

Additionally, Merck will be liable for sales, logistics and application technology customer support. Poppy seed extract is a skin-firming substance with a dual mechanism of action.

Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.

Procter&Gamble Healt Share Price

5090.50 69.20 (1.38%)
20-Apr-2026 15:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.50
Dr. Reddys Lab 1233.20
Cipla 1232.00
Zydus Lifesciences 937.70
Lupin 2327.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×